The University of Chicago Header Logo

Connection

Olwen Hahn to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Dose-Response Relationship, Drug.
Olwen Hahn
Connection Strength
0.023
Dose-Response Relationship, Drug
  1. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015 Jan 01; 33(1):13-21.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.